Aubagio
PHONETIC PRONUNCIATION: Aubagio
Description
Aubagio: Everything You Need to Know About This Medication Aubagio, also known as Teriflunomide, is a prescription medication used to treat multiple sclerosis (MS). This medication is classified as an immunomodulator, which means it works by inhibiting the immune system's response that attacks the central nervous system (CNS). Uses: Aubagio is commonly prescribed for the following purposes: 1. To treat MS relapse: Aubagio has proven to be effective in reducing MS relapse rates in patients. 2. To decrease CNS inflammation: Aubagio reduces inflammation in the CNS by inhibiting the production of lymphocytes that contribute to inflammation. Dosage: The dosage of Aubagio may vary depending on the patient's age, sex, weight, and other factors. Generally, the dosage recommended is 14mg orally daily. Dosage adjustments may be required if the patient experiences severe side effects or other issues. Demographic: Aubagio is primarily prescribed for adults with relapsing forms of multiple sclerosis. This medication is not recommended for use in children under the age of 18 years. Side Effects: Like all medications, Aubagio has a list of potential side effects. Common side effects may include Diarrhea, nausea, hair loss, liver problems, etc. Other less common side effects include infections, skin rashes, flu-like symptoms, and decreased white blood cell count. Interactions: Aubagio can interact with other medications, including drugs used to treat HIV/AIDS, cancer, and other autoimmune diseases. Patients should inform their doctors about any medications they are taking before starting Aubagio. Generic Options: Currently, there are no generic versions of Aubagio available on the market. In conclusion, Aubagio is a potent medication that is highly effective in treating MS relapses. However, patients should be aware of any potential side effects and inform their doctors of any other medications they may be taking. While no generic options are currently available, Aubagio is a vital medication for those with MS. With proper dosage and supervision, it can make a significant difference in the lives of those living with this condition.
Faq for Aubagio
Aubagio is used to treat relapsing forms of multiple sclerosis (MS). It is an oral medication that helps to reduce the frequency of MS relapses and slow down the progression of the disease.
Aubagio works by suppressing the immune system, specifically the activated T-lymphocytes, which are involved in the inflammation that causes damage to the nervous system in MS.
The recommended dosage of Aubagio for adults is 14 mg once daily, taken orally. It is important to follow the prescribed dosage as directed by your healthcare provider.
Yes, there are some common side effects of Aubagio, including diarrhea, nausea, hair thinning or loss, increased liver enzymes, and skin rash. It is essential to inform your doctor if you experience any side effects.
Aubagio can cause harm to an unborn baby. It is not recommended to take Aubagio if you are pregnant or planning to become pregnant. It is crucial to discuss your pregnancy plans with your healthcare provider before starting or continuing Aubagio.
Aubagio may interact with certain medications, including other immune-suppressing drugs or those that affect the liver. Inform your doctor about all the medications you are taking to avoid any potential drug interactions.
Aubagio's effectiveness may vary from person to person. Generally, it may take a few weeks to a few months to experience the full benefits of the medication. It is important to continue taking Aubagio as prescribed, even if you do not notice immediate improvement.
Aubagio is not a cure for multiple sclerosis. However, it can help manage the symptoms, reduce the frequency of relapses, and slow down the progression of the disease.
Drinking alcohol while taking Aubagio may increase the risk of liver toxicity. It is recommended to avoid or limit alcohol consumption while on this medication. It is important to discuss alcohol use with your healthcare provider.